Examples of 'studied in patients' in a sentence
Meaning of "studied in patients"
pertains to the examination or analysis of a medical treatment, drug, or procedure that is being evaluated or tested on individuals who are receiving medical care
How to use "studied in patients" in a sentence
Basic
Advanced
studied in patients
Tivicay has not been studied in patients on dialysis.
Not studied in patients with history of pancreatitis.
Juluca has not been studied in patients on dialysis.
Not studied in patients with terminal stage of renal failure or hemodialysis.
Rilpivirine has not been studied in patients.
These are being studied in patients with fibromyalgia as well.
The pharmacokinetics of hydrochlorothiazide has not been studied in patients with cardiac failure.
Has not been studied in patients with a history of pancreatitis.
The pharmacokinetics of omalizumab have been studied in patients with allergic asthma.
Valsartan has been studied in patients with post myocardial infarction and heart failure.
The pharmacokinetics of palbociclib have not been studied in patients requiring haemodialysis.
Vandetanib has not been studied in patients with ventricular arrhythmias or recent myocardial infarction.
Ritonavir pharmacokinetic parameters have not been studied in patients with renal impairment.
Doptelet was not studied in patients with prior thromboembolic events.
Efficacy and safety of sevelamer hydrochloride has not been studied in patients with.
Sycrest was also studied in patients with schizophrenia.
The safety and efficacy of BindRen has not been studied in patients with.
Natpar has not been studied in patients with urolithiasis.
The use of Elidel under occlusion has not been studied in patients.
Temsirolimus has not been studied in patients undergoing haemodialysis.
The use of Protopic ointment under occlusion has not been studied in patients.
Rimonabant has not been studied in patients being treated for epilepsy.
The use of Protopy ointment under occlusion has not been studied in patients.
Busulfan has not been studied in patients with hepatic impairment.
The single and multiple dose pharmacokinetics of lanadelumab have been studied in patients with HAE.
Zavesca has not been studied in patients with liver problems.
Agenerase capsules ( without the boosting effect of ritonavir ) have been studied in patients with.
Cerdelga has not been studied in patients with hepatic impairment.
Efficacy and safety of Renagel has not been studied in patients with,.
Thiotepa has not been studied in patients with hepatic impairment.
However, the systemic effects of nocturnal hypoxemia have been little studied in patients with COPD.
Cerdelga has not been studied in patients with renal impairment.
The use of < Invented Name > under occlusion has not been studied in patients.
Visudyne has not been studied in patients with renal impairment.
It was not until the 1990s that it was formally studied in patients.
Numient has not been studied in patients with hepatic impairment.
Elderly patients Pharmacokinetics of cannabidiol have not been studied in patients > 55 years of age.
Numient has not been studied in patients with renal impairment.
Although axitinib dose adjustment has not been studied in patients receiving strong.
Yellox has not been studied in patients with hepatic disease or renal impairment.
The hemodynamic effects of intravenous salbutamol were studied in patients with mitral valve disease.
Possia has not been studied in patients with moderate or severe hepatic impairment.
The pharmacokinetics of deferasirox have not been studied in patients with renal impairment.
Lucentis has not been studied in patients who have previously received intravitreal injections.
The pharmacokinetics of emtricitabine has not been studied in patients with hepatic impairment.
Idelalisib has not been studied in patients with chronic active hepatitis including viral hepatitis.
The pharmacokinetics of emtricitabine have not been studied in patients with hepatic impairment.
Gilenya was not studied in patients with renal impairment in the multiple sclerosis pivotal studies.
Pegaptanib pharmacokinetics have not been studied in patients with hepatic impairment.
NovoSeven has been studied in patients with haemophilia and in patients with factor VII deficiency.
You'll also be interested in:
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
Examples of using Studied
Show more
This subject is studied for five years
Studied all about you quiet guys
It has not been studied in these age groups
